van der Sandt IC - Search Results

1

Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.

van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD. van der Sandt IC, et al. AIDS. 2001 Mar 9;15(4):483-91. doi: 10.1097/00002030-200103090-00007. AIDS. 2001. PMID: 11242145

2

The role of drug transporters at the blood-brain barrier.

de Boer AG, van der Sandt IC, Gaillard PJ. de Boer AG, et al. Among authors: van der sandt ic. Annu Rev Pharmacol Toxicol. 2003;43:629-56. doi: 10.1146/annurev.pharmtox.43.100901.140204. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12415123 Review.

3

Transporters and the blood-brain barrier (BBB).

De Boer AB, De Lange EL, Van der Sandt IC, Breimer DD. De Boer AB, et al. Among authors: van der sandt ic. Int J Clin Pharmacol Ther. 1998 Jan;36(1):14-5. Int J Clin Pharmacol Ther. 1998. PMID: 9476143 No abstract available.

4

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.

van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD. van der Sandt IC, et al. Eur J Pharm Sci. 2000 Sep;11(3):207-14. doi: 10.1016/s0928-0987(00)00097-x. Eur J Pharm Sci. 2000. PMID: 11042226

5

Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

Gaillard PJ, van der Sandt IC, Voorwinden LH, Vu D, Nielsen JL, de Boer AG, Breimer DD. Gaillard PJ, et al. Among authors: van der sandt ic. Pharm Res. 2000 Oct;17(10):1198-205. doi: 10.1023/a:1026406528530. Pharm Res. 2000. PMID: 11145224

6

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

van der Sandt IC, Smolders R, Nabulsi L, Zuideveld KP, de Boer AG, Breimer DD. van der Sandt IC, et al. Eur J Pharm Sci. 2001 Aug;14(1):81-6. doi: 10.1016/s0928-0987(01)00150-6. Eur J Pharm Sci. 2001. PMID: 11457654

7

P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

van der Sandt IC, Gaillard PJ, Voorwinden HH, de Boer AG, Breimer DD. van der Sandt IC, et al. Pharm Res. 2001 May;18(5):587-92. doi: 10.1023/a:1011016923346. Pharm Res. 2001. PMID: 11465412

8

The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone.

Karssen AM, Meijer OC, van der Sandt IC, De Boer AG, De Lange EC, De Kloet ER. Karssen AM, et al. Among authors: van der sandt ic. J Endocrinol. 2002 Oct;175(1):251-60. doi: 10.1677/joe.0.1750251. J Endocrinol. 2002. PMID: 12379510

9

In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.

de Lange EC, Marchand S, van den Berg D, van der Sandt IC, de Boer AG, Delon A, Bouquet S, Couet W. de Lange EC, et al. Among authors: van der sandt ic. Eur J Pharm Sci. 2000 Dec;12(2):85-93. doi: 10.1016/s0928-0987(00)00149-4. Eur J Pharm Sci. 2000. PMID: 11102735

10

Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.

Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER. Karssen AM, et al. Among authors: van der sandt ic. Endocrinology. 2001 Jun;142(6):2686-94. doi: 10.1210/endo.142.6.8213. Endocrinology. 2001. PMID: 11356720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page